文献速递冠心病血脂与心血管预防

自身免疫性疾病与冠状动脉粥样硬化严重程度及缺血事件的关联

Association of Autoimmune Diseases With Coronary Atherosclerosis Severity and Ischemic Events.
PubMed 文献 · J Am Coll Cardiol · 2024-01-01

基于丹麦西部心脏注册中心85,512例接受冠状动脉CT血管造影的患者,评估18种自身免疫性疾病与冠状动脉粥样硬化及动脉粥样硬化性心血管疾病(ASCVD)风险的关联。中位随访5.3年期间发生3,832例ASCVD事件,自身免疫性疾病与任何斑块、任何冠状动脉钙化(CAC)及CAC>90百分位独立相关,并增加46%的ASCVD风险,传统心血管危险因素可放大该风险。

要点

  • 自身免疫性疾病独立增加冠状动脉粥样硬化斑块和钙化负荷,尤其严重钙化风险更高。
  • 自身免疫性疾病患者未来ASCVD事件风险增加46%,传统危险因素可进一步放大风险。
  • 自身免疫病患者若心血管危险因素控制良好,ASCVD风险可降低约54%。

核心结论

  • 自身免疫性疾病独立关联更高的冠状动脉粥样硬化负荷和未来ASCVD事件风险,传统心血管危险因素可加重该风险。

研究设计与样本

  • 研究纳入丹麦西部心脏注册中心85,512例接受冠状动脉CT血管造影的患者,评估18种自身免疫性疾病诊断。
  • 计算任何斑块、任何CAC、CAC>90百分位及阻塞性冠心病的调整OR,以及ASCVD的调整HR。

主要发现

  • 中位随访5.3年(Q1-Q3:2.8-8.2年)期间发生3,832例ASCVD事件,4,064例患者有自身免疫性疾病诊断。
  • 自身免疫性疾病与任何斑块(aOR:1.29;95%CI:1.20-1.40)、任何CAC(aOR:1.28;95%CI:1.19-1.37)及CAC>90百分位(aOR:1.53;95%CI:1.39-1.68)相关。
  • 自身免疫性疾病与阻塞性冠心病无显著关联(aOR:1.04;95%CI:0.91-1.17)。
  • 自身免疫性疾病患者ASCVD风险增加46%(aHR:1.46;95%CI:1.29-1.65)。
  • 自身免疫病患者中有利的心血管危险因素谱与较有危险因素者约54%的较低风险相关(aHR:0.46;95%CI:0.27-0.81)。

临床怎么用

  • 对自身免疫性疾病患者应积极评估和管理传统心血管危险因素以改善预后。
  • 冠状动脉CT血管造影可用于评估自身免疫病患者的粥样硬化负荷,但需结合临床判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Some autoimmune diseases carry elevated risk for atherosclerotic cardiovascular disease (ASCVD), yet the underlying mechanism and the influence of traditional risk factors remain unclear. OBJECTIVES: This study sought to determine whether autoimmune diseases independently correlate with coronary atherosclerosis and ASCVD risk and whether traditional cardiovascular risk factors modulate the risk. METHODS: The study included 85,512 patients from the Western Denmark Heart Registry undergoing coronary computed tomography angiography. A diagnosis of 1 of 18 autoimmune diseases was assessed. Adjusted OR (aOR) for any plaque, any coronary artery calcification (CAC), CAC of >90th percentile, and obstructive coronary artery disease as well as adjusted HR (aHR) for ASCVD were calculated. RESULTS: During 5.3 years (Q1-Q3: 2.8-8.2 years) of follow-up, 3,832 ASCVD events occurred. A total of 4,064 patients had a diagnosis of autoimmune disease, which was associated with both presence of any plaque (aOR: 1.29; 95% CI: 1.20-1.40), any CAC (aOR: 1.28; 95% CI: 1.19-1.37), and severe CAC of >90th percentile (aOR: 1.53; 95% CI: 1.39-1.68), but not with having obstructive coronary artery disease (aOR: 1.04; 95% CI: 0.91-1.17). Patients with autoimmune diseases had a 46% higher risk (aHR: 1.46; 95% CI: 1.29-1.65) for ASCVD. Traditional cardiovascular risk factors were strongly associated with future ASCVD events, and a favorable cardiovascular risk factor profile in autoimmune patients was associated with ∼54% lower risk compared to patients with presence of risk factors (aHR: 0.46; 95% CI: 0.27-0.81). CONCLUSIONS: Autoimmune diseases were independently associated with higher burden of coronary atherosclerosis and higher risk for future ASCVD events, with risk accentuated by traditional cardiovascular risk factors. These findings suggest that autoimmune diseases increase risk through accelerated atherogenesis and that cardiovascular risk factor control is key for improving prognosis in patients with autoimmune diseases.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Mortensen MB, Jensen JM, Rønnow Sand NP, et al. Association of Autoimmune Diseases With Coronary Atherosclerosis Severity and Ischemic Events. J Am Coll Cardiol. 2024. PMID: 38897674. doi:10.1016/j.jacc.2024.04.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。